Daily Symptom Fluctuations and Functional Impact in Fibromyalgia
Relationship Between Daily Symptom Fluctuations and Functional Impact in Fibromyalgia
1 other identifier
observational
150
1 country
1
Brief Summary
Fibromyalgia is a chronic condition that commonly causes widespread pain, fatigue, and difficulty in daily activities. These symptoms may change from day to day, even when their average severity is similar. This study aims to examine whether daily changes in pain and fatigue are related to functional impact in adults with fibromyalgia. Participants will complete clinical questionnaires at the first visit and record their pain and fatigue levels for seven days. Sleep quality and perceived control over symptoms will also be recorded. No treatment or additional medical procedure will be given as part of the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2026
CompletedFirst Submitted
Initial submission to the registry
September 12, 2026
CompletedFirst Posted
Study publicly available on registry
September 17, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 15, 2027
September 17, 2026
September 1, 2026
7 months
September 12, 2026
September 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Functional Impact Assessed by the Fibromyalgia Impact Questionnaire
Functional impact will be assessed using the Fibromyalgia Impact Questionnaire (FIQ). The total score ranges from 0 to 100, with higher scores indicating greater impact of fibromyalgia. The main analysis will examine whether within-person variability in pain and fatigue over seven days is associated with the FIQ score independently of average pain and fatigue levels.
At the initial visit
Secondary Outcomes (4)
Within-Person Association Between Pain and Fatigue
During the 7-day monitoring period
Maximum Pain and Fatigue Levels
During the 7-day monitoring period
Perceived Symptom Control
During the 7-day monitoring period
Sleep Quality
During the 7-day monitoring period
Study Arms (1)
Adults With Fibromyalgia
Adults aged 18-65 years who meet the 2016 American College of Rheumatology criteria for fibromyalgia will be included. Participants will complete clinical questionnaires at the initial visit and record pain and fatigue levels for seven days. Sleep quality and perceived symptom control will also be recorded. No treatment or experimental intervention will be administered as part of the study.
Eligibility Criteria
The study population will consist of adults aged 18-65 years who attend the Physical Medicine and Rehabilitation outpatient clinic of Mardin Training and Research Hospital and meet the 2016 American College of Rheumatology criteria for fibromyalgia. Both female and male participants will be included. All participants must be able to complete the seven-day symptom records and provide written informed consent. No healthy control group will be included.
You may qualify if:
- Diagnosis of fibromyalgia according to the 2016 American College of Rheumatology criteria
- Age between 18 and 65 years
- Ability to understand and complete the daily symptom records
- Ability and willingness to provide written informed consent
You may not qualify if:
- Active inflammatory rheumatic disease
- Major neurological disease
- Major change in fibromyalgia treatment within the previous three months
- Pregnancy, postpartum period, or breastfeeding
- Cognitive impairment or inability to provide informed consent
- Completion of less than 70% of the required daily symptom records
- Major change in fibromyalgia treatment during the seven-day monitoring period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mardin Training and Research Hospital
Mardin, 47100, Turkey (Türkiye)
Related Publications (3)
Bartley EJ, Robinson ME, Staud R. Pain and Fatigue Variability Patterns Distinguish Subgroups of Fibromyalgia Patients. J Pain. 2018 Apr;19(4):372-381. doi: 10.1016/j.jpain.2017.11.014. Epub 2017 Dec 15.
PMID: 29253551BACKGROUNDAffleck G, Urrows S, Tennen H, Higgins P, Abeles M. Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia. Pain. 1996 Dec;68(2-3):363-8. doi: 10.1016/s0304-3959(96)03226-5.
PMID: 9121825BACKGROUNDHarris RE, Williams DA, McLean SA, Sen A, Hufford M, Gendreau RM, Gracely RH, Clauw DJ. Characterization and consequences of pain variability in individuals with fibromyalgia. Arthritis Rheum. 2005 Nov;52(11):3670-4. doi: 10.1002/art.21407.
PMID: 16258905BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D.
Study Record Dates
First Submitted
September 12, 2026
First Posted
September 17, 2026
Study Start
August 1, 2026
Primary Completion (Estimated)
February 15, 2027
Study Completion (Estimated)
February 15, 2027
Last Updated
September 17, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share